Health3 hours ago
Citi Initiates Coverage of Biohaven with Buy Rating, Target set at $28
Shares of Biohaven Pharmaceutical Holding Company Ltd. surged on Wednesday morning after Citi initiated coverage with a Buy rating, setting a price target of $28 per...